(READ) FDA limits J&J Covid-19 vaccine due to blood clot risk, Sharyl Attkisson, on May 13, 2022 at 2:17 am Sharyl Attkisson

The following information is from the FDA re: its decision to limit use of J&J Covid-19 vaccine due to blood clot risk. Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines, , Read More, Sharyl Attkisson

Leave a Reply

Your email address will not be published.

Generated by Feedzy